| http://www.w3.org/ns/prov#value | - We have reanalyzed the data from 3 double-blind trials of linoleic acid in the treatment of MS. Our most important finding is that patients with minimal or no disability at entry had a significantly smaller increase in disability over the course of the trials than did control patients.
|
